PharmaCyte Biotech, Inc.
PMCB · NASDAQ
7/31/2025 | 4/30/2025 | 1/31/2025 | 10/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$8,360 | $11,750 | -$3,045 | -$1,470 |
| Dep. & Amort. | $0 | $0 | $0 | $0 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $60 | $64 | $73 | $119 |
| Change in WC | $0 | $1,258 | $422 | -$126 |
| Other Non-Cash | $6,306 | -$14,112 | $2,040 | $421 |
| Operating Cash Flow | -$1,994 | -$1,040 | -$510 | -$1,055 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | $0 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $7,000 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $0 | $0 | $0 | $7,000 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $0 | $0 | $0 | $0 |
| Stock Repurch. | $0 | -$172 | -$3,945 | -$10,740 |
| Dividends Paid | $0 | $0 | $0 | -$16,190 |
| Other Fin. Act. | $0 | $0 | -$3,720 | $6,853 |
| Financing Cash Flow | $0 | -$172 | -$3,945 | -$10,740 |
| Forex Effect | $0 | $1 | -$1 | $0 |
| Net Chg. in Cash | -$1,994 | -$1,211 | -$4,457 | -$11,795 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $15,172 | $16,383 | $20,840 | $32,635 |
| End Cash | $13,178 | $15,172 | $16,383 | $20,840 |
| Free Cash Flow | -$1,994 | -$1,040 | -$510 | -$1,055 |